Lippuner, Kurt
Moghadam, Bita Yousefi
Schwab, Patrick
Funding for this research was provided by:
University of Bern
Article History
Received: 25 August 2022
Accepted: 19 December 2022
First Online: 18 January 2023
Declarations
:
: This is not required by Swiss law for database analyses without individual patient data
: This is not applicable.
: None was declared by BYM and PS. KL has served as an expert in advisory board meetings of Amgen Switzerland AG and UCB Pharma AG Switzerland.